Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088140
Status:
COMPLETED
Last Update Posted:
2012-08-13
First Post:
2004-07-20
Brief Title:
A Caspase Inhibitor in Chronic Hepatitis C HCV Patients
Sponsor:
Conatus Pharmaceuticals Inc
Organization:
Conatus Pharmaceuticals Inc
Study Overview
Official Title:
A Dose Response Study of a Caspase Inhibitor in Hepatitis C Patients
Status:
COMPLETED
Status Verified Date:
2012-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if IDN-6556 when given orally is safe and effective in patients with chronic hepatitis C virus infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None